dc.contributor.author |
Hasriadi |
|
dc.contributor.author |
Wasana, Peththa Wadu Dasuni |
|
dc.contributor.author |
Suwattananuruk, Piyapan |
|
dc.contributor.author |
Thompho, Somphob |
|
dc.contributor.author |
Thitikornpong, Worathat |
|
dc.contributor.author |
Vajragupta, Opa |
|
dc.contributor.author |
Rojsitthisak, Pornchai |
|
dc.contributor.author |
Towiwat, Pasarapa |
|
dc.date.accessioned |
2023-02-08T09:25:16Z |
|
dc.date.available |
2023-02-08T09:25:16Z |
|
dc.date.issued |
2022-08-05 |
|
dc.identifier.citation |
Hasriadi, Dasuni Wasana, P. W., Suwattananuruk, P., Thompho, S., Thitikornpong, W., Vajragupta, O., ... & Towiwat, P. (2022). Curcumin Diethyl γ-Aminobutyrate, a Prodrug of Curcumin, for Enhanced Treatment of Inflammatory Pain. ACS Pharmacology & Translational Science, 5(9), 774-790. |
en_US |
dc.identifier.issn |
2575-9108 |
|
dc.identifier.uri |
http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/10912 |
|
dc.description.abstract |
Curcumin is a naturally occurring polyphenol compound with potential analgesic effects. It has been shown to improve pain-like behaviors in numerous models of pain. Despite its potential, curcumin exhibits poor physicochemical and pharmacokinetic properties, which hinder its oral therapeutic efficacy. Curcumin diethyl γ-aminobutyrate (CUR-2GE), a carbamate prodrug of curcumin, was designed to overcome these limitations and demonstrated greater anti-neuroinflammatory effects compared to curcumin in vitro. Thus, this study evaluated the effect of CUR-2GE and its parent compound on pain-like behaviors in carrageenan- and LPS-induced mouse models. The possible side effects of CUR-2GE were also assessed by exploring its effects on motor coordination and spontaneous locomotor activity after acute and chronic treatments. The results showed that CUR-2GE improved mechanical and thermal hyperalgesia and locomotor activity to a greater extent than curcumin in carrageenan-induced mice. These results are in line with the ability of CUR-2GE to suppress peripheral inflammation in the paw tissue of carrageenan-induced mice, indicated by a significant decrease in TNF-α and IL-6 expression levels. Similarly, in LPS-induced mice, CUR-2GE improved sickness and pain-like behaviors (exploratory behaviors and long-term locomotor activity) to a greater extent than curcumin. Furthermore, CUR-2GE significantly reduced the level of proinflammatory cytokines in both the plasma and spinal cord tissue of LPS-induced mice, exhibiting significantly higher inhibition than curcumin. Moreover, the motor coordination, and locomotive behaviors of mice were not affected by both acute and chronic administration of CUR-2GE, indicating no potential CNS side effects. Thus, CUR-2GE demonstrated enhanced therapeutic efficacy in mouse models of inflammatory pain without any possible CNS side effects, suggesting its potential to be developed as an analgesic agent against inflammatory pain. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
American Chemical Society |
en_US |
dc.subject |
Inflammatory pain |
en_US |
dc.subject |
carrageenan |
en_US |
dc.subject |
LPS |
en_US |
dc.subject |
curcumin |
en_US |
dc.subject |
curcumin diethyl γ-aminobutyrate |
en_US |
dc.subject |
inflammation |
en_US |
dc.title |
Curcumin Diethyl γ-Aminobutyrate, a Prodrug of Curcumin, for Enhanced Treatment of Inflammatory Pain |
en_US |
dc.type |
Article |
en_US |